BROWSE BY
0
Eidos Therapeutics, Inc. Banner Image

Eidos Therapeutics, Inc.

  • Ticker EIDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eidos Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Eidos is developing acoramidis, a potentially disease-modifying therapy for the treatment of ATTR.
Visit website
REPORT RATINGS
4.7 / 5.0 (81)

Eidos Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 81 reviews.

Eidos Therapeutics, Inc.

Most Recent Annual Report

Eidos Therapeutics, Inc.
MOST RECENT 2019 Annual Report and Form 10K
View PDF View Form 10K (HTML)

Older/Archived Annual Reports

x
Eidos Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!